Market Considerations Amid a growing body of clinical evidence demonstrating the therapeutic benefits of psychedelics as medicine, Mydecine is positioning for opportunity across growing sectors. The global smoking cessation market is expected to increase at a CAGR of 16.9% to reach nearly $64 billion by 2026. The psychedelic therapeutics market, which is in its very early stages, shows wide-ranging estimates for the current value and expected growth. Market forecasts range from $6.5 billion by 2030 to more than $69 billion as soon as 2025, growing at CAGRs from 8.2% and 15%, respectively.
RkJQdWJsaXNoZXIy NDMyMDk=